Vertex Pharmaceuticals, Inc.
(NASDAQ : VRTX)

( )
VRTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -5.23%207.410.0%$1713.99m
BIIBBiogen, Inc. 2.40%406.141.7%$1308.00m
SNSSSunesis Pharmaceuticals, Inc. 9.01%12.950.7%$905.25m
NVAXNovavax, Inc. -0.94%207.7179.8%$703.35m
AMGNAmgen, Inc. -0.65%241.191.3%$607.30m
BNTXBioNTech SE -7.53%220.580.0%$521.84m
GILDGilead Sciences, Inc. 0.13%68.151.0%$461.62m
VRTXVertex Pharmaceuticals, Inc. 0.92%194.801.9%$449.28m
ILMNIllumina, Inc. -0.23%452.143.5%$372.79m
REGNRegeneron Pharmaceuticals, Inc. 0.61%528.752.7%$364.34m
ALXNAlexion Pharmaceuticals, Inc. 0.00%181.652.0%$341.36m
OCGNOcugen, Inc. -3.31%6.130.0%$262.85m
EXASEXACT Sciences Corp. 2.56%125.0118.1%$192.21m
BNGOBionano Genomics, Inc. 3.17%7.820.0%$186.15m
ONTXOnconova Therapeutics, Inc. 6.93%7.561.8%$181.22m

Company Profile

Vertex Pharmaceuticals, Inc. is a global biotechnology company. It engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.